Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by fredgoodwinsonon Jun 29, 2021 5:00am
299 Views
Post# 33464789

RE:RE:RE:Trademark Destroying Cancer at the Speed of Light

RE:RE:RE:Trademark Destroying Cancer at the Speed of Light

Also taking this trademark as a positive. In securing ’Destroying cancer at the speed of light’  as their logo (and an excellent one) and since likely confined to the use of TLD1433/Rutherrin atm the logical conclusion is that Rutherrin is destroying cancer at the speed of light - and this is actually something that they’ve been telling us in a succession of Quarterlies.

 

If they can show safety and proof of principle in deep seated cancers next year Rutherrin will have breached the dam and unless the US wishes to leave the field clear for Theralase until after 2050 they would have to deal with TLT to release the whole suite of metal based photo/radiosensitisers that Sherri has developed there. By that stage Theralase`s hand would be a whole lot stronger.

 
<< Previous
Bullboard Posts
Next >>